Suppr超能文献

比迪烟烟草及主流烟气中烟草特有亚硝胺的评估。

Assessment of tobacco-specific nitrosamines in the tobacco and mainstream smoke of Bidi cigarettes.

作者信息

Wu Weijia, Song Siqing, Ashley David L, Watson Clifford H

机构信息

Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop F-47, Atlanta, GA 30341, USA.

出版信息

Carcinogenesis. 2004 Feb;25(2):283-7. doi: 10.1093/carcin/bgh004. Epub 2003 Nov 6.

Abstract

Bidi cigarettes, or bidis, are a tobacco product that originated in India and have been gaining popularity in the USA during the past few years, particularly with adolescents. As with conventional cigarettes, tobacco and smoke from bidis contain chemical constituents including carcinogenic chemicals such as the tobacco-specific nitrosamines (TSNAs). To help better assess the potential public health risk associated with bidi cigarettes, we developed modern high throughput methods to accurately quantify TSNA levels in tobacco and mainstream cigarette smoke particulate. We determined the TSNA levels in the tobacco filler and mainstream smoke from 14 bidi cigarette brands. In the bidi tobacco filler, the 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) levels ranged from 0.09 to 0.85 microg/g, while N'-nitrosonornicotine (NNN) levels ranged from 0.15 to 1.44 microg/g. These amounts are comparable with those in typical American blended cigarettes. The levels of NNK in mainstream smoke from bidis ranged from 2.13 to 25.9 ng/cigarette, and NNN levels ranged from 8.56 to 62.3 ng/cigarette. The wide variation in the TSNA levels most probably reflects the hand-rolled nature of the bidi cigarettes, resulting in a product with less homogenous tobacco amount and a wider variation in overall cigarette construction quality. TSNA levels of bidis were comparable with those of conventional cigarettes, and bidis should not be considered a lower-risk alternative tobacco product. Our analytical findings concur with the previous biologic and biochemical evidence supporting epidemiologic studies linking bidi use with various cancers, especially oral cavity and lung cancers.

摘要

比迪烟,又称小卷烟,是一种起源于印度的烟草产品,在过去几年中在美国越来越受欢迎,尤其是在青少年中。与传统香烟一样,比迪烟中的烟草和烟雾含有化学成分,包括致癌化学物质,如烟草特异性亚硝胺(TSNAs)。为了更好地评估与比迪烟相关的潜在公共健康风险,我们开发了现代高通量方法,以准确量化烟草和主流卷烟烟雾颗粒中的TSNA水平。我们测定了14个比迪烟品牌的烟草填充物和主流烟雾中的TSNA水平。在比迪烟的烟草填充物中,4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)水平在0.09至0.85微克/克之间,而N'-亚硝基去甲烟碱(NNN)水平在0.15至1.44微克/克之间。这些含量与典型的美国混合型香烟相当。比迪烟主流烟雾中的NNK水平在2.13至25.9纳克/支之间,NNN水平在8.56至62.3纳克/支之间。TSNA水平的广泛差异很可能反映了比迪烟的手工卷制性质,导致产品的烟草含量不均匀,整体卷烟结构质量差异更大。比迪烟的TSNA水平与传统香烟相当,不应被视为低风险的替代烟草产品。我们的分析结果与先前支持流行病学研究的生物学和生化证据一致,这些研究将比迪烟的使用与各种癌症联系起来,尤其是口腔癌和肺癌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验